Psyence Group Inc. (CSE:PSYG)

Market Cap	2.66M
Revenue (ttm)	n/a
Net Income (ttm)	-400.23K
Shares Out	15.64M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,000
Average Volume	2,185
Open	0.1700
Previous Close	0.1700
Day's Range	0.1700 - 0.1700
52-Week Range	0.1050 - 0.5250
Beta	1.23
RSI	65.98
Earnings Date	Jul 30, 2025

About Psyence Group

Psyence Group Inc., a life science biotechnology company, engages in the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma. It operates in two segments, Clinical Trial Activities and Non-Clinical Trial Activities. The company develops botanical psilocybin-based psychedelic medicine, which works with natural psilocybin products for the healing of psychological trauma and its mental health consequences in the context of palliative care. It also focuses on the research and development, c...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 2019
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: PSYG